Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Numit is a topical anesthetic cream containing a eutectic mixture of lidocaine (2.5% w/w) and prilocaine (2.5% w/w) in a 1:1 oil-in-water emulsion. Developed and manufactured by Ego Pharmaceuticals, it is designed for dermal anesthesia by blocking voltage-gated sodium channels in peripheral nerve endings, which prevents the initiation and conduction of nerve impulses. The product is indicated for use prior to procedures such as intravenous catheterization, blood sampling, vaccinations, and minor surgical or cosmetic procedures. It has also been investigated in clinical trials at Queensland Children's Hospital for pain management during pediatric laser treatments for vascular malformations and scars.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + prilocaine (Ego Pharmaceuticals).